Accounts payable and accrued expenses consist of the following (in thousands):


	March 31, 2026		December 31, 2025
Accounts payable	$	31,537	$	37,220
Accrued salaries and incentive compensation		92,765		248,058
Accrued payroll taxes and benefits		24,487		39,620
Accrued professional liabilities		33,994		35,176
Accrued interest		2,775		8,151
Other accrued expenses		51,372		51,305
	$	236,930	$	419,530

The net decrease in accrued salaries and incentive compensation of $155.3 million, from December 31, 2025 to March 31, 2026, is primarily due to the payment of performance-based incentive compensation, principally to the Company’s affiliated physicians, partially offset by performance-based incentive compensation accrued during the three months ended March 31, 2026. A majority of the Company’s payments for performance-based incentive compensation is paid annually during the first quarter.